• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 相关的器官衰竭和炎症:关注细胞和病毒 microRNAs 的作用。

SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs.

机构信息

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Virol J. 2023 Aug 9;20(1):179. doi: 10.1186/s12985-023-02152-6.

DOI:10.1186/s12985-023-02152-6
PMID:37559103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10413769/
Abstract

SARS-CoV-2 has been responsible for the recent pandemic all over the world, which has caused many complications. One of the hallmarks of SARS-CoV-2 infection is an induced immune dysregulation, in some cases resulting in cytokine storm syndrome, acute respiratory distress syndrome and many organs such as lungs, brain, and heart that are affected during the SARS-CoV-2 infection. Several physiological parameters are altered as a result of infection and cytokine storm. Among them, microRNAs (miRNAs) might reflect this poor condition since they play a significant role in immune cellular performance including inflammatory responses. Both host and viral-encoded miRNAs are crucial for the successful infection of SARS-CoV-2. For instance, dysregulation of miRNAs that modulate multiple genes expressed in COVID-19 patients with comorbidities (e.g., type 2 diabetes, and cerebrovascular disorders) could affect the severity of the disease. Therefore, altered expression levels of circulating miRNAs might be helpful to diagnose this illness and forecast whether a COVID-19 patient could develop a severe state of the disease. Moreover, a number of miRNAs could inhibit the expression of proteins, such as ACE2, TMPRSS2, spike, and Nsp12, involved in the life cycle of SARS-CoV-2. Accordingly, miRNAs represent potential biomarkers and therapeutic targets for this devastating viral disease. In the current study, we investigated modifications in miRNA expression and their influence on COVID-19 disease recovery, which may be employed as a therapy strategy to minimize COVID-19-related disorders.

摘要

SARS-CoV-2 是导致全球近期大流行的元凶,引发了许多并发症。SARS-CoV-2 感染的特征之一是诱导免疫失调,在某些情况下会导致细胞因子风暴综合征、急性呼吸窘迫综合征以及肺部、大脑和心脏等许多器官受累。感染和细胞因子风暴会导致多种生理参数发生改变。其中,微小 RNA(miRNA)可能反映了这种不良状态,因为它们在免疫细胞功能中发挥着重要作用,包括炎症反应。宿主和病毒编码的 miRNA 对于 SARS-CoV-2 的成功感染都至关重要。例如,调节 COVID-19 合并症患者(如 2 型糖尿病和脑血管疾病)多个基因表达的 miRNA 失调可能会影响疾病的严重程度。因此,循环 miRNA 的表达水平改变可能有助于诊断这种疾病,并预测 COVID-19 患者是否会发展为严重状态。此外,许多 miRNA 可以抑制 SARS-CoV-2 生命周期中涉及的蛋白质,如 ACE2、TMPRSS2、刺突和 Nsp12 的表达。因此,miRNA 是这种破坏性病毒疾病的潜在生物标志物和治疗靶点。在本研究中,我们研究了 miRNA 表达的变化及其对 COVID-19 疾病恢复的影响,这可能被用作一种治疗策略,以最小化与 COVID-19 相关的疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a28c/10413769/c029a0b60d0c/12985_2023_2152_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a28c/10413769/c029a0b60d0c/12985_2023_2152_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a28c/10413769/c029a0b60d0c/12985_2023_2152_Fig1_HTML.jpg

相似文献

1
SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs.SARS-CoV-2 相关的器官衰竭和炎症:关注细胞和病毒 microRNAs 的作用。
Virol J. 2023 Aug 9;20(1):179. doi: 10.1186/s12985-023-02152-6.
2
The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review.微小 RNA 在解决新冠病毒感染到治疗的谜题中的作用:一篇迷你综述。
Virus Res. 2022 Jan 15;308:198631. doi: 10.1016/j.virusres.2021.198631. Epub 2021 Nov 14.
3
The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.microRNAs 在调节人类细胞中 SARS-CoV-2 感染中的作用:系统评价。
Infect Genet Evol. 2021 Jul;91:104832. doi: 10.1016/j.meegid.2021.104832. Epub 2021 Apr 1.
4
Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells.SARS-CoV-2 核衣壳基因编码的病毒 microRNAs 在感染过程中被检测到,并靶向宿主细胞中的代谢途径。
Cells. 2021 Jul 12;10(7):1762. doi: 10.3390/cells10071762.
5
Deciphering the link between Diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas.通过对人胰腺中 microRNAs 的差异靶向作用来破译糖尿病与 SARS-CoV-2 感染之间的联系。
J Endocrinol Invest. 2022 Mar;45(3):537-550. doi: 10.1007/s40618-021-01693-3. Epub 2021 Oct 20.
6
Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients.与 COVID-19 患者疾病严重程度和预后相关的循环 microRNA 特征。
Front Immunol. 2022 Aug 11;13:968991. doi: 10.3389/fimmu.2022.968991. eCollection 2022.
7
MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review.微小 RNA 在开发针对 COVID-19 的潜在治疗靶点中的作用:叙事性综述。
J Infect Public Health. 2022 Jul;15(7):788-799. doi: 10.1016/j.jiph.2022.06.012. Epub 2022 Jun 21.
8
Circulating microRNA profiling is altered in the acute respiratory distress syndrome related to SARS-CoV-2 infection.循环 microRNA 谱在与 SARS-CoV-2 感染相关的急性呼吸窘迫综合征中发生改变。
Sci Rep. 2022 Apr 28;12(1):6929. doi: 10.1038/s41598-022-10738-3.
9
miR-1207-5p Can Contribute to Dysregulation of Inflammatory Response in COVID-19 Targeting SARS-CoV-2 RNA.miR-1207-5p 可通过靶向 SARS-CoV-2 RNA 导致 COVID-19 中炎症反应失调。
Front Cell Infect Microbiol. 2020 Oct 29;10:586592. doi: 10.3389/fcimb.2020.586592. eCollection 2020.
10
Circulating microRNAs as emerging regulators of COVID-19.循环 microRNAs 作为 COVID-19 的新兴调控因子。
Theranostics. 2023 Jan 1;13(1):125-147. doi: 10.7150/thno.78164. eCollection 2023.

引用本文的文献

1
A State-of-the-Art Review on the Recent Advances in Exosomes in Oncogenic Virus.关于致癌病毒中外泌体最新进展的综述
Health Sci Rep. 2024 Nov 18;7(11):e70196. doi: 10.1002/hsr2.70196. eCollection 2024 Nov.
2
SARS-CoV-2 Vaccine Improved Hemostasis of a Patient with Protein S Deficiency: A Case Report.SARS-CoV-2 疫苗改善了蛋白 S 缺乏症患者的止血功能:一例报告。
Int J Mol Sci. 2024 Oct 5;25(19):10717. doi: 10.3390/ijms251910717.
3
Identification and evaluation of candidate COVID-19 critical genes and medicinal drugs related to plasma cells.

本文引用的文献

1
Immune-checkpoint expression in antigen-presenting cells (APCs) of cytomegaloviruses infection after transplantation: as a diagnostic biomarker.移植后巨细胞病毒感染中抗原呈递细胞的免疫检查点表达:作为一种诊断生物标志物。
Arch Microbiol. 2023 Jul 10;205(8):280. doi: 10.1007/s00203-023-03623-8.
2
Dynamic alterations in white blood cell counts and SARS-CoV-2 shedding in saliva: an infection predictor parameter.唾液中白细胞计数和新型冠状病毒脱落情况的动态变化:一种感染预测参数。
Front Med (Lausanne). 2023 Jun 15;10:1208928. doi: 10.3389/fmed.2023.1208928. eCollection 2023.
3
The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness.
鉴定和评估与浆细胞相关的候选 COVID-19 关键基因和药物。
BMC Infect Dis. 2024 Oct 3;24(1):1099. doi: 10.1186/s12879-024-10000-3.
4
Gene expression profile of mitogen-activated kinases and microRNAs controlling their expression in HaCaT cell culture treated with lipopolysaccharide A and cyclosporine A.丝裂原活化蛋白激酶基因表达谱及其调控细胞培养物中 HaCaT 细胞表达的 microRNAs 受脂多糖 A 和环孢素 A 的影响。
Cell Cycle. 2024 Feb;23(3):279-293. doi: 10.1080/15384101.2024.2320508. Epub 2024 Mar 6.
5
The biomarkers' landscape of post-COVID-19 patients can suggest selective clinical interventions.新冠病毒感染后患者的生物标志物图谱可提示有选择性的临床干预措施。
Sci Rep. 2023 Dec 15;13(1):22496. doi: 10.1038/s41598-023-49601-4.
新冠肺炎患者不同疾病严重程度的 miRNA 神经炎症生物标志物。
Neurologia (Engl Ed). 2023 Jul-Aug;38(6):e41-e51. doi: 10.1016/j.nrleng.2023.05.002.
4
PBMC MicroRNAs: Promising Biomarkers for the Differential Diagnosis of COVID-19 Patients with Abnormal Coagulation Indices.外周血单个核细胞 microRNAs:鉴别诊断 COVID-19 伴异常凝血指数患者的有潜力的生物标志物。
Curr Microbiol. 2023 Jun 21;80(8):248. doi: 10.1007/s00284-023-03365-2.
5
Increase in rabies cases during COVID-19 pandemic: Is there a connection?新冠疫情期间狂犬病病例增加:两者有关联吗?
J Infect Dev Ctries. 2023 Mar 31;17(3):335-336. doi: 10.3855/jidc.17537.
6
A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases.COVID-19 症状和治疗在自身免疫性疾病中的全面综述。
Virol J. 2023 Jan 7;20(1):1. doi: 10.1186/s12985-023-01967-7.
7
Current evidence of COVID-19 vaccination-related cardiovascular events.新型冠状病毒肺炎疫苗接种相关心血管事件的当前证据。
Postgrad Med. 2023 Mar;135(2):102-120. doi: 10.1080/00325481.2022.2161249. Epub 2023 Jan 3.
8
Hepatic Disorders and COVID-19: From Pathophysiology to Treatment Strategy.肝脏疾病与 COVID-19:从病理生理学到治疗策略。
Can J Gastroenterol Hepatol. 2022 Dec 8;2022:4291758. doi: 10.1155/2022/4291758. eCollection 2022.
9
Diagnostic accuracy of clinically applied nanoparticle-based biosensors at detecting SARS-CoV-2 RNA and surface proteins in pharyngeal swabs compared to RT-PCR as a reference test.临床应用的基于纳米粒子的生物传感器在检测咽拭子中的 SARS-CoV-2 RNA 和表面蛋白方面的诊断准确性与 RT-PCR 作为参考测试的比较。
Expert Rev Mol Diagn. 2022 Sep;22(9):881-894. doi: 10.1080/14737159.2022.2135434. Epub 2022 Oct 19.
10
Virus, Exosome, and MicroRNA: New Insights into Autophagy.病毒、外泌体和 microRNA:自噬的新见解。
Adv Exp Med Biol. 2022;1401:97-162. doi: 10.1007/5584_2022_715.